U.S. Medical Equipment Stock News

If you are wondering whether Cboe Global Markets is offering fair value at its current price, this article will walk through how the market might be pricing the stock today. Cboe shares last closed at US$273.55, with returns of 4.8% over 7 days, 8.4% over 30 days, 10.3% year to date, 42.1% over 1 year and 132.3% over 3 years. This gives important context before comparing the price to underlying value. Recent coverage has focused on Cboe's role as a major exchange group and provider of...

Why Plains All American Pipeline’s latest moves matter for income-focused investors Plains All American Pipeline (PAA) has combined a higher common unit cash distribution with a refocused crude oil portfolio, following the EPIC Crude acquisition and the sale of its Canadian NGL business. The partnership now reports a quarterly cash distribution of $0.4175 per common unit, or $1.67 on an annualized basis, alongside detailed preferred distributions across its Series A and Series B units. For...

If you are wondering whether Main Street Capital's current share price lines up with its underlying value, you are not alone. That is exactly what this article aims to unpack. The stock last closed at US$63.96, with returns of 4.5% over the past week, 5.7% over the past month, 3.6% year to date and 14.4% over the past year, plus a very large gain over five years. Recent coverage has focused on Main Street Capital's role in providing financing to lower middle market companies and how that...

Recent commentary on MPLX LP highlighted its more than 8% distribution yield, a 12.5% distribution increase, and resilient midstream cash flows supported by energy infrastructure demand, contributing to a more constructive view of the partnership earlier this week. Analysts and AI-driven trading frameworks have underscored how MPLX’s stable EBITDA contributions to Marathon Petroleum and potential benefits from growing data center-driven natural gas use could underpin its long-term income...

TSS, Inc. recently presented at the 28th Annual Needham Growth Conference at The Lotte New York Palace Hotel in New York, featuring Chief Financial Officer Daniel M. Chism and CEO, President & Director Darryll E. Dewan. This conference appearance gave management a high-visibility platform to communicate TSS’s business direction and priorities directly to a concentrated investor audience. We’ll now look at how investor expectations around TSS’s Needham conference presentation may influence...

Baird previously downgraded Sunstone Hotel Investors from Outperform to Neutral, citing a less favorable outlook versus hotel REIT peers despite the company’s continued dividend growth track record. The research house specifically contrasted Sunstone with competitors expected to benefit more directly from major upcoming events, highlighting how relative catalysts can influence investor preference within the lodging REIT sector. We’ll now explore how Baird’s less favorable peer comparison may...

Why Comcast (CMCSA) is on investors’ radar today Comcast (CMCSA) has drawn fresh attention after recent trading, with the share price at $27.82 and negative returns over the past month and past 3 months prompting closer scrutiny of the media and connectivity group. See our latest analysis for Comcast. Recent trading has been weak, with a 1 month share price return of an 8.25% decline and a year to date share price return of a 5.82% decline, while the 1 year total shareholder return of a...

Lemonade (LMND) is back on many investors’ screens after a quarterly report that paired strong in-force premium growth with a lower gross loss ratio, sharply higher gross profit, and positive adjusted free cash flow. See our latest analysis for Lemonade. That improvement story has been playing out in the share price too, with Lemonade’s 90 day share price return of 65.02% and 1 year total shareholder return of 141.88% suggesting momentum has picked up meaningfully despite a modest year to...

Why Orchid Island Capital (ORC) is back on dividend investors’ radar Orchid Island Capital (ORC) has drawn fresh attention after releasing preliminary fourth quarter 2025 figures, including estimated net income of $0.62 per share, book value of $7.54, and RMBS related gains. See our latest analysis for Orchid Island Capital. That preliminary update and the recently affirmed monthly dividend of US$0.12 for January 2026 come as Orchid Island Capital’s share price has climbed to US$8.33, with a...

This article is designed to help you assess whether Goldman Sachs Group, at around US$962 a share, still offers value or if most of the opportunity is already reflected in the price. The stock has recently recorded returns of 2.5% over 7 days, 10.3% over 30 days, 5.2% year to date and 56.8% over the past year, along with a very large 3 year gain and a 274.4% return over 5 years. These results may influence how you think about potential future upside and risk. Recent coverage around Goldman...

FMC Corporation has faced a difficult period, missing revenue expectations in multiple 2025 earnings reports, slashing its dividend by 86% to conserve cash, and moving to sell its India business while working through cash collection issues in South America. Management has signalled that a meaningful recovery is unlikely before 2028, underscoring how pricing pressure from generics, elevated debt and operational headwinds are reshaping FMC’s priorities and financial flexibility. With FMC...

Becton, Dickinson and Company recently received FDA 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, while also committing US$110.00 million to expand BD Neopak Glass Prefillable Syringe production in Columbus, Nebraska to support biologic and GLP-1 drug delivery. These moves broaden BD’s breast health and pharmaceutical systems portfolios, tying clinical diagnostics innovation directly to reshoring and strengthening of the U.S. drug delivery supply...

Why Thermo Fisher Scientific (TMO) is back in focus Thermo Fisher Scientific (TMO) is drawing fresh attention as it reshapes its top leadership, closes a U.S. manufacturing site, and leans into new AI partnerships with NVIDIA and TetraScience around lab automation and data. See our latest analysis for Thermo Fisher Scientific. At a share price of US$618.72, Thermo Fisher has seen a 30 day share price return of 9.98% and a 90 day share price return of 14.81%, while the 1 year total shareholder...

If you are wondering whether Expeditors International of Washington at US$162.41 is offering good value right now, it helps to step back and look at what the current price might be implying. The stock has posted returns of 2.2% over the last 7 days, 8.5% over 30 days, 6.9% year to date, 49.0% over 1 year and 57.7% over 3 years, with a 5 year return of 83.4%. This naturally raises questions about how much of the story is already priced in. Recent attention on Expeditors has centered on its...

Earlier this month, Krystal Biotech reported a positive interim update from the highest-dose cohort of its Phase 1 CORAL-1 study, showing successful lung delivery and expression of wild-type CFTR protein with inhaled gene therapy candidate KB407 in cystic fibrosis patients. This progress in validating in-lung gene delivery with KB407 adds a new potential pillar to Krystal’s HSV-1-based platform beyond its existing dermatology franchise. We’ll now examine how KB407’s early success in...

If you are wondering whether Rollins is priced attractively right now, it helps to start by lining up the recent share performance with what you are actually getting for the current price. The stock last closed at US$62.73, with returns of 3.4% over 7 days, 4.1% over 30 days, 6.3% year to date, 31.1% over 1 year, 80.7% over 3 years and 80.4% over 5 years. This raises questions about how much of the story is already reflected in the share price. Recent coverage around Rollins has focused on...

Why Vicor is back on investors' radar Vicor (VICR) has moved back into focus after analyst upgrades tied to its royalty outlook, advanced Vertical Power Delivery work, and a fresh two year license deal with an existing OEM customer. See our latest analysis for Vicor. That shift in sentiment has lined up with a sharp move in the share price, with a 30 day share price return of 54.21% and a 90 day share price return of 160.98%. Together, these have contributed to a 1 year total shareholder...

Why GRAIL’s latest guidance and new coverage matter for investors GRAIL (GRAL) recently issued 2025 revenue guidance of US$147 million to US$148 million, indicating 17% to 18% growth over 2024, alongside fresh analyst coverage that adds another reference point for investor expectations. See our latest analysis for GRAIL. The latest 2025 revenue guidance and fresh Wall Street coverage have arrived after a sharp re-rating, with a 12.61% 1 month share price return and a very large 1 year total...

Monolithic Power Systems (MPWR) has moved into the spotlight after Wells Fargo shifted its rating on the power chip designer from Equal Weight to Overweight, citing what it describes as improving sentiment across the semiconductor sector. See our latest analysis for Monolithic Power Systems. The Wells Fargo upgrade comes after a strong stretch of momentum, with a 7 day share price return of 7.74%, a 30 day share price return of 13.26%, and a 1 year total shareholder return of 66.46%. This...

Why Omnicom Group is Drawing Fresh Attention Omnicom Group (OMC) is back on many investors’ radars after recent share price moves, with the stock closing at US$79.79 and showing mixed returns over the past year and past 3 months. See our latest analysis for Omnicom Group. Recent trading has been mixed, with a 1 day share price return of a 1.30% decline and a 30 day share price return of a 3.52% decline, contrasted with a 5 year total shareholder return of 51.90%. This indicates that short...

Customers Bancorp recently appointed Sam Sidhu to its Board of Directors, effective January 1, 2026, as part of a planned leadership transition that also sees Jay Sidhu serving as Executive Chairman. The bank also reported a Net Promoter Score of 81 for 2025, an 8-point improvement that underscores unusually strong client satisfaction and service differentiation across its franchise. We will now examine how this surge in client satisfaction aligns with Customers Bancorp’s existing investment...

What Parsons’ Recent Performance Tells You With no single headline event driving attention today, Parsons (PSN) is on some investors’ radar because of its recent share performance and financial profile, which together sketch out a clearer picture of the business. See our latest analysis for Parsons. Over the past month, Parsons’ 20.38% share price return has come after a softer 90 day patch. When you set that against a 1 year total shareholder return of a 23.90% decline and a 3 year total...

If you are wondering whether Daqo New Energy offers good value at its current share price, you are not alone. This article will walk through what the numbers are and what they might mean for you as an investor. The stock has seen a mixed return profile, with a 1.6% decline over the last 7 days, a 21.2% decline over the last 30 days, a 15.1% decline year to date, a 32.0% gain over the last year, a 46.8% decline over 3 years, and a 74.0% decline over 5 years. Recent news flow around Daqo New...

Dover recently announced that it will release its fourth-quarter 2025 earnings on January 29, 2026, followed by a same-day conference call for investors to review its latest financial and operational performance. At the same time, an upgrade from UBS highlighting Dover’s improving growth prospects and perceived undervaluation versus industrial peers has drawn fresh attention to how the company could participate in a cyclical recovery in industrial orders. Now we’ll examine how this UBS...